The Miriam Hospital

The Miriam Hospital Lifespan Division, a tax-exempt nonprofit hospital division based in Providence, Rhode Island, serves as a prime recipient on federal grants and a subrecipient on collaborative research grants, with a portfolio concentrated in behavioral health research, infectious disease prevention, obesity and weight management interventions, and clinical training programs funded by the National Institutes of Health and the Department of Veterans Affairs.

The hospital operates as the research and clinical arm of the Lifespan health system, with Rhode Island Hospital and Wentworth Corporation as named subsidiaries. Recent activity spans 402 awards across 41 federal customer agencies, with the portfolio weighted heavily toward NIH funding. The National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute on Drug Abuse, and the National Heart Lung and Blood Institute represent the top three NIH customer institutes by award count. Over the past five years, awards have grown from 15 in 2022 to a peak of 50 in 2024, though 2025 and 2026 show moderation at 27 and 17 awards respectively. The Department of Veterans Affairs Veterans Integrated Service Network 1 places recurring small purchase orders for Qualitative Science Methods Training Programs, with awards valued at $12,000 to $17,850 each. The Army awards clinical laboratory services under an indefinite delivery contract (W912LD04A0004), with 77 task orders totaling $350 thousand combined potential value. Prime awards account for 75% of the portfolio; 25% are subrecipient positions under research grants from Brown University, Duke University, Northwestern University, and other academic institutions.

The hospital's capability portfolio centers on behavioral health research and clinical interventions. Representative prime grant work includes a $1.531 million NIDA Project Grant on ovarian hormone effects on electronic nicotine delivery systems use among young women, with sub-awardees including Brown University, Rhode Island Hospital, and Arkansas Children's Research Institute; a $705 thousand NIMH Project Grant developing an AI-based behavioral chatbot (CHIA) to improve HIV pre-exposure prophylaxis uptake among men who have sex with men; a $200 thousand NIAID Project Grant on an STI prevention AI-chatbot (SAI) for doxycycline post-exposure prophylaxis; and multiple NIDDK-funded trials on weight loss maintenance, obesity interventions, and eating disorder prevention. The hospital also conducts research on prenatal mindfulness training to prevent hypertensive disorders of pregnancy, trauma-informed obstetric care, and substance use treatment outcomes. Clinical training programs include K23 and K01 career development awards in cardiovascular behavioral medicine, adolescent weight management, trauma-informed obstetric care, and substance use research. As a subrecipient, the hospital contributes site leadership and clinical oversight to multi-site randomized trials, qualitative research methods expertise, and participant recruitment and retention in studies led by Brown University, Rhode Island Hospital, and regional academic partners.

Twenty-seven awards face ultimate completion within the next twenty-four months, surfacing recompete opportunity. The hospital does not compete under set-asides; all work is full-and-open federal funding. The combined potential value across all awards stands at $28.4 million, although obligated dollars ($441.1 million) substantially exceed potential value, reflecting prior-year invoicing on long-term research grants. Primary place of performance is Providence, Rhode Island, with some clinical and research activities at affiliated Rhode Island Hospital and subordinate Lifespan locations.